Seldon Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BIO
Seldon Capital's BIO Position: Q3 2026 in Review
Seldon Capital opened a new position in Bio-Rad Laboratories Class A (BIO) in Q3 2026: 11,563 shares worth $4.37M. The stake represents 1.27% of the portfolio and ranks #25 among its holdings.
419 funds tracked by Wall St. Rank hold BIO as of Q3 2026.
- Seldon Capital held 11,563 shares of Bio-Rad Laboratories Class A worth $4.37M as of Q3 2026.
- Bio-Rad Laboratories Class A was a new Seldon Capital position in Q3 2026.
- Bio-Rad Laboratories Class A made up 1.27% of Seldon Capital's portfolio in Q3 2026, its #25 holding.
- 419 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.
Based on Seldon Capital's 13F filing for Q3 2026, filed 16 Nov 2026.